The role of nebulised budesonide in the treatment of acute exacerbations of COPD

Gunen H., Hacievliyagil S. S., Yetkin O., Gulbas G.

Source: Eur Respir J 2007; 30: 399-400
Journal Issue: August
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gunen H., Hacievliyagil S. S., Yetkin O., Gulbas G.. The role of nebulised budesonide in the treatment of acute exacerbations of COPD. Eur Respir J 2007; 30: 399-400

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of nebulised budesonide in the treatment of exacerbations of COPD
Source: Eur Respir J 2007; 29: 660-667
Year: 2007



Clinical efficacy of nebulised budesonide in acute exacerbation of COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Comparison of oral prednisolone and nebulized budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001

Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Aerosolized fluticasone propionate therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 45s
Year: 2002

Comparison of different dosage nebulised budesonide in COPD exacerbation
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


Efficacy of a combination therapy with single inhaler budesonide/formoterol in the treatment of acute exacerbations of COPD (AECOPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 252s
Year: 2004

Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Severe exacerbations, decline in lung function and inhaled budesonide in asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007

The role of inhaled corticosteroids in the management of acute asthma
Source: Eur Respir J 2007; 30: 1035-1037
Year: 2007


Nebulized therapy in bronchial asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Effect of discontinuation of inhaled fluticasone propionate on exacerbations in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 183s
Year: 2001

The role of bronchodilator treatment in the prevention of exacerbations of COPD
Source: Eur Respir J 2012; 40: 1545-1554
Year: 2012



Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006

N-acetylcysteine for the treatment of acute exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 374s
Year: 2002